The weekly litigation news digest is live. Subscribe now

IP Verse

Treating Infections With Ceftolozane/Tazobactam In Subjects Having Impaired Renal Function - EP3043797

The patent EP3043797 was granted to Merck Sharp & Dohme on Apr 8, 2020. The application was filed on Sep 9, 2014 under application number EP14842042A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3043797

MERCK SHARP & DOHME
Application Number
EP14842042A
Filing Date
Sep 9, 2014
Status
Opposition Rejected
Nov 25, 2022
Publication Date
Apr 8, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBDec 21, 2020LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB -

Patent Citations (2) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2013065874
SEARCHUS2013065874

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents